Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies

Annals of Clinical and Translational Neurology(2019)10.1002/acn3.50897Source: DataRank Database

α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies is a research paper published in Annals of Clinical and Translational Neurology (2019). On theSindex it has a DataRank of 0.778. It has been cited 178 times.

N/A

0.778DataRank · unranked

Scored on demand from live citation data

178 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 11.02)OA: goldTopics (34)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.778

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (19)

Anna Ladogana ORCID,Stefano Capaldi ORCID,Sigrid Klotz,Simone Baiardi ORCID,Annachiara Cagnin

Live enrichment

PubMed:31599499 PMC:PMC6801172 OpenAlex:https://openalex.org/W2980298807

Ministero della Salute

Grant: RF‐2013‐02354884 and GR-2013-02355724

Regione del Veneto

Grant: RP‐2014‐00000400

Ministero della Salute, Italy

Grant: RF-2013-02354884 and GR-2013-02355724

Veneto Region

Grant: RP-2014-00000400

NIA NIH HHS

Grant: P30 AG010133

National Institutes of Health

Grant: 5P30AG010133-08

CORE-- EDUCATION AND INFORMATION TRANSFER

FWCI

11.02

Citation Percentile

1.0%

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.50897

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.50897

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.50897

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/acn3.50897

journalhttps://doi.org/10.1002/acn3.50897

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeurological and metabolic disorders03 medical and health sciences0302 clinical medicine

MeSH Terms

Alzheimer DiseaseBiological AssayDiagnosis, DifferentialHumansCreutzfeldt-Jakob SyndromeSensitivity and SpecificityLewy Body Diseasealpha-Synuclein

Keywords

MedicineDementia with Lewy bodiesCerebrospinal fluidDementiaPathologyDiseaseLewy Body DiseaseDementia with Lewy bodies (DLB); α‐synuclein; RT‐QuIC; diagnostic toolNeurosciences. Biological psychiatry. NeuropsychiatryCLINICAL DIAGNOSTIC-CRITERIA, ALZHEIMERS-DISEASE, DLB, HUMAN PRIONSSensitivity and SpecificityCreutzfeldt-Jakob SyndromeDiagnosis, DifferentialAlzheimer Diseasealpha-SynucleinHumansBiological AssayNeurology. Diseases of the nervous systemRC346-429Brief CommunicationsRC321-571

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 4 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163347.v1figshare

Additional file 4 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163347figshare

Additional file 1 of High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

10.6084/m9.figshare.16944567.v1figshare

Additional file 1 of High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

10.6084/m9.figshare.16944567figshare

Additional file 1 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163335.v1figshare

Additional file 1 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163335figshare

Additional file 2 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163338.v1figshare

Additional file 2 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163338figshare

Additional file 3 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163344.v1figshare

Additional file 3 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163344figshare

Additional file 5 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163353.v1figshare

Additional file 5 of Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

10.6084/m9.figshare.17163353figshare

Additional file 1 of Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease

10.6084/m9.figshare.20130877.v1figshare

Additional file 1 of Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease

10.6084/m9.figshare.20130877figshare

Additional file 1 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

10.6084/m9.figshare.24647135.v1figshare

Additional file 1 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

10.6084/m9.figshare.24647135figshare

Additional file 1 of Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies

10.6084/m9.figshare.26170575.v1figshare

Additional file 1 of Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies

10.6084/m9.figshare.26170575figshare

Additional file 8 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

10.6084/m9.figshare.26645827.v1figshare

Additional file 8 of Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

10.6084/m9.figshare.26645827figshare

α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies

FAIR Checklist

DataRank Breakdown

Authors (19)

Funding (6 grants)

Impact

Open Access

Topics

Linked Datasets (25)